MOUNT VERNON, NY / ACCESSWIRE / June 21, 2021 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, today announced the signing of a Master Distributor agreement for the United States with FSG, one of the of the nation's largest lighting distributors and electrical contractors, for the SteriLumen portfolio of air and surface disinfection devices.
"The disinfection market has been very significant for FSG with over $10 million dollars in sales in 2020, and we expect similar volume opportunities with Applied UV over the coming year," said Bernie Erickson, Executive Vice President and Director of Innovation for FSG. "What really attracted FSG to the Applied portfolio of solutions is the strong science behind the products. We appreciate the ability to offer the highest quality and technology to our customers and we are very excited to bring our relationship with Applied UV to an entirely new level."
As a Master Distributor, FSG is partnering with Applied UV in areas including distribution, logistics, support, and other high-value services such as installation and technical support for SteriLumen's Lumicide™ platform for infection control on hard surfaces and its Airocide® products for air purification. Lumicide™ utilizes UVC LEDs for infection control in and around high-traffic areas, killing bacteria, viruses, and other pathogens residing on hard surfaces within devices' proximity. SteriLumen's Airocide® products for air purification utilize a proprietary photo-catalytic bioconversion technology that converts damaging molds, microorganisms, dangerous pathogens, destructive VOCs, and biological gasses into harmless water vapor without producing ozone or other harmful byproducts. For more than 38 years, FSG has provided electrical, lighting and technology services and support to a wide range of commercial customers, Including restaurants, hospitality, retail, education, transportation, healthcare, and offices.
"Selecting the right distribution partner to help us successfully extend our brand and product into the commercial market was an important decision for Applied UV," said Q Saeed, CEO of Applied UV. "We are delighted to be partnering with FSG, which has a proven track record of market leadership, technical innovation, and high-levels of customer service."
About FSG
FSG was founded in 1982 and has grown from a small lighting distributor in San Antonio Texas, to one of the nation's largest lighting distributors and electrical contractors. Today, FSG employs more than 2000 employees nationwide and works with more than a thousand affiliate vendors from all four corners of the nation. FSG's customers list includes every type of business from top name multisite consumer brands to general contractors, to local neighborhood businesses.
About Applied UV
Applied UV is focused on the development and acquisition of technology that address infection control in the healthcare, hospitality, commercial and municipal markets. The Company has two wholly owned subsidiaries - SteriLumen, Inc. ("SteriLumen") and Munn Works, LLC ("Munn Works"). SteriLumen's connected platform for Data Driven Disinfection™ applies the power of ultraviolet light (UVC) to destroy pathogens safely, thoroughly, and automatically, addressing the challenge of healthcare-acquired infections ("HAIs"). Targeted for use in facilities that have high customer turnover such as hospitals, hotels, commercial facilities, and other public spaces, the Company's Lumicide™ platform uses UVC LEDs in several patented designs for infection control in and around high-traffic areas, including sinks and restrooms, killing bacteria, viruses, and other pathogens residing on hard surfaces within devices' proximity. The Company's patented in-drain disinfection device, Lumicide Drain, is the only product on the market that addresses this critical pathogen intensive location. SteriLumen's Airocide® products for air purification, developed by NASA and FDA Cleared as class II medical devices, utilize a proprietary photo-catalytic bioconversion technology that draws air into a reaction chamber that converts damaging molds, microorganisms, dangerous pathogens, destructive VOCs and biological gasses into harmless water vapor without producing ozone or other harmful byproducts. Airocide® applications include healthcare, hospitality, grocery chains, wine making facilities, commercial real estate, schools, dental offices, and homes.
For more information about Applied UV, Inc., and its subsidiaries, please visit the following websites: https://www.applieduvinc.com/; https://sterilumen.com/; and, https://munnworks.com/.
Forward-Looking Statements
The information contained herein may contain "forward‐looking statements." Forward‐looking statements reflect the current view about future events. When used in this press release, the words "anticipate," "believe," "estimate," "expect," "future," "intend," "plan," or the negative of these terms and similar expressions, as they relate to us or our management, identify forward‐looking statements. Such statements include, but are not limited to, statements contained in this press release relating to the view of management of Applied UV concerning its business strategy, future operating results and liquidity and capital resources outlook. Forward‐looking statements are based on the Company's current expectations and assumptions regarding its business, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. The Company's actual results may differ materially from those contemplated by the forward‐looking statements. They are neither statements of historical fact nor guarantees of assurance of future performance. We caution you therefore against relying on any of these forward‐looking statements. Factors or events that could cause the Company's actual results to differ may emerge from time to time, and it is not possible for the Company to predict all of them. The Company cannot guarantee future results, levels of activity, performance, or achievements. Except as required by applicable law, including the securities laws of the United States, the Company does not intend to update any of the forward‐looking statements to conform these statements to actual results.
Applied UV Investor Relations
TraDigital IR
Kevin McGrath
+1 (646) 418-7002
[email protected]
SOURCE: Applied UV, Inc.